Skip to main content
Earnings Labs
Prelude Therapeutics Incorporated logo

Prelude Therapeutics Incorporated (PRLD)

NASDAQ·Healthcare·Biotechnology

$4.21

+0.24%

Mkt Cap $259.69M

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (6 analysts)

$8.00

Range $8.00$8.00

Implied Upside

+90.0%

Consensus $8.00 vs current $4.21